kiran mazumdar shaw speaks on the q2 numbers of biocon | halftime report | cnbc-tv18
Published 1 year ago • 786 plays • Length 10:10
Download video MP4
Download video MP3
Similar videos
-
25:46
live | biocon is not for sale, ignore rumours: founder kiran mazumdar-shaw | india ideas summit
-
14:47
key stocks in focus: l&t, biocon, tata power, dabur, irb infra, tci express, manappuram finance
-
13:57
kiran mazumdar-shaw denies biocon sale rumours, focuses on debt reduction & global expansion
-
5:23
biocon eyes equity investments for debt reduction says kiran mazumdar-shaw | exclusive | cnbc tv18
-
5:24
serum takes its investment in biocon bio to $300 million, kiran m shaw on this & more | cnbc-tv18
-
10:18
biocon q1 fy12 results - kiran mazumdar shaw, cnbc tv 18
-
10:10
federal bank reports strong q2 growth amidst market challenges: can it sustain this momentum?
-
6:48
growth in q2 was mainly from the prestige & above segment: allied blenders & distillers | cnbc tv18
-
8:12
cams strong q2 results: how is the company driving growth amid market challenges? | et now
-
4:16
company is exploring equity investment opportunities to reduce debt: biocon's kiran mazumdar-shaw
-
1:57
dabur reports weak q2, volumes decline, key ratios miss street expectations | cnbc tv18
-
6:50
biocon's kiran mazumdar shaw on strong q4, biosimilar business & fy24 outlook | halftime report
-
12:50
kiran mazumdar-shaw, executive chairperson, biocon & biocon biologics speaking on q1 & fy25 results
-
9:12
biocon: q2fy18: cmd- kiran mazumdar shaw - cnbc tv18
-
7:01
biocon q3 net profit falls 25%, revenue jumps 36%: kiran mazumdar shaw exclusive | cnbc-tv18
-
1:43
five-star biz finance reports strong q2 earnings, cuts fy25 credit growth guidance | cnbc tv18
-
7:50
kiran mazumdar shaw shares her views on biocon biologics acquiring viatris biosimilar's business
-
1:39
bofa initiates buy rating on biocon, cuts target price to ₹330 from ₹390 | halftime report
-
16:28
biocon cmd kiran mazumdar-shaw speaks to cnbc-tv18 on status of ema dossiers
-
4:33
biocon biologics's shreehas tambe speaks on us fda's observation | bazaar open exchange | cnbc-tv18
-
5:33
kiran mazumdar shaw speaks on the biocon deal
-
12:28
biocon q4 below estimates
Clip.africa.com - Privacy-policy